Health
Pfizer says BNT162b2 vaccine is effective against new Covid strains – Pharmaceutical Business Review
Pfizer said that BNT162b2 has been found to be effective against a key mutation found in two highly transmissible strains of the SARS-CoV-2 virus.
Pfizer and BioNTech said that their Covid-19 vaccine BNT162b2 has been found to be effective against a key mutation found in two highly transmissible strains of the SARS-CoV-2 virus as per the results from an in vitro study.
The in vitro study, which was held by Pfizer and the University of Texas Medical Branch (UTMB), demonstrated that the antibodies from people subjected to the vaccine could effectively work against the rapidly spreading variants.
Reported initially in the UK and South Africa,…
-
Noosa News22 hours agoQueensland teachers strike for second time this year after rejecting 8 per cent wage rise
-
General22 hours agoVictorian government blocked fire service from pursuing US giant over PFAS contamination
-
Noosa News13 hours agoWest Coast Eagles draftee Josh Lindsay wants to carry on Troy Selwood’s legacy
-
General14 hours agoLabor to squeeze public service, sparking warnings of job losses